Belantamab Mafodotin in Combination with Pomalidomide and Dexamethasone Demonstrates Durable Responses in Triple Class Exposed/Refractory Multiple Myeloma Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Trudel, Suzanne
  • McCurdy, Arleigh
  • Fu, Molei
  • Sutherland, Heather J
  • Louzada, Martha L
  • Chu, Michael P
  • White, Darrell J
  • Mian, Hira
  • Kotb, Rami
  • Othman, Ibraheem
  • Kardjadj, Moustafa
  • Gul, Engin
  • Reece, Donna E

publication date

  • November 15, 2022

published in